Pain Management EHR

Pain Management CPT Codes and EHR Billing Support

Pain management billing spans more CPT code categories than almost any other outpatient specialty: epidural steroid injections, facet and medial branch blocks, radiofrequency ablation, spinal cord stimulator trials, trigger point injections, nerve blocks, urine drug screening, and the new 2026 chronic pain management codes. Each category carries distinct documentation requirements, prior authorization rules, and bundling restrictions. A missing laterality designation on a facet injection, an undocumented diagnostic block result before RFA, or a fluoroscopy add-on that became bundled in 2017 will generate a denial or an audit finding. OmniMD’s AI medical scribe captures procedure note documentation at the specificity level required to support the correct code and defend it on review. Verified on 2026-06-19 by Dr. Giri.

Interventional Procedure CPT Codes

Urine Drug Screening, 2026 Chronic Pain Codes, and RPM

Source: CMS 2026 Medicare Physician Fee Schedule (conversion factor $32.35/RVU). See the AI RCM software page for how OmniMD handles prior authorization tracking for RFA, SCS, and ESI procedures across commercial and Medicare payers.

PDMP Compliance and Controlled Substance Management

As of 2026, 40 states mandate that a clinician check the Prescription Drug Monitoring Program (PDMP) database before prescribing a controlled substance. In states with mandatory PDMP laws, a missed check is both a compliance violation and a professional liability exposure. Manual PDMP checks through state web portals take 2 to 4 minutes per patient and generate no documented audit trail in the chart. OmniMD queries the state PDMP automatically when the patient chart opens, imports the results directly into the opioid safety dashboard, and records the exact timestamp of the check as a permanent element of the encounter record. For practices prescribing Schedule II through V controlled substances across a full day schedule, this eliminates the manual portal login workflow entirely.

• Opioid Risk Tool (ORT): OmniMD includes the ORT as a structured intake screening instrument. A score of 3 or below indicates low risk for opioid misuse. Scores of 4 through 7 indicate moderate risk; 8 or above indicates high risk. OmniMD stores the ORT score in the patient record and alerts the provider when the score warrants a higher monitoring frequency or a treatment agreement review. Source: CMS opioid prescribing resources.
• SOAPP-R (Screener and Opioid Assessment for Patients with Pain): The SOAPP-R is a 24-item validated instrument for identifying patients at risk for opioid misuse before initiating long-term opioid therapy. A score below 18 indicates lower risk. OmniMD includes SOAPP-R as a structured pre-therapy intake form, stores results longitudinally, and includes the score in the prior authorization documentation summary for opioid therapy requests.
• MME calculator with CDC thresholds: OmniMD calculates the morphine milligram equivalent (MME) for each opioid prescription automatically. The CDC guideline identifies 50 MME per day as the threshold for increased monitoring and 90 MME per day as the high-risk designation. Example: oxycodone 10mg three times daily = 30mg per day x 1.5 conversion factor = 45 MME per day. OmniMD recalculates MME on every prescription change and displays the current daily MME prominently in the prescribing workflow, with a red alert when the 90 MME threshold is crossed.
• Controlled substance agreement tracking: Pain management practices using long-term opioid therapy require a signed controlled substance agreement as part of the treatment relationship. OmniMD tracks agreement signature dates, expiration dates, and renewal due dates for every patient on controlled substance therapy. The system sends internal alerts when an agreement is within 30 days of expiration and prevents controlled substance prescriptions when the agreement has lapsed, creating an automatic compliance checkpoint without requiring manual calendar tracking.
• Multi-prescriber detection and pill count documentation: OmniMD’s PDMP integration flags patients who appear in the state database with prescriptions from multiple controlled substance prescribers. The flag appears in the chart before the encounter begins, giving the provider visibility before entering the room. Pill count documentation workflows are built into the follow-up visit template, with fields for count date, actual versus expected count, and clinical response to any discrepancy.

Interventional Procedure Documentation Templates

Each interventional pain management procedure type requires a distinct documentation structure. An epidural steroid injection note must specify the approach (interlaminar versus transforaminal), the spinal level, the injectate type and volume, fluoroscopy findings including contrast spread pattern, and any vascular uptake observation. A medial branch block note must document the relief percentage at the 30-minute and 2-hour marks to establish diagnostic block results for future RFA candidacy. A spinal cord stimulator trial note must document the trial success criteria before the permanent implant can be authorized. OmniMD provides separate structured procedure note templates for each of these procedure types, with required fields that the provider cannot complete the note without addressing.

• Epidural Steroid Injection (ESI) template: OmniMD’s ESI template captures approach (interlaminar vs. transforaminal), spinal level with laterality, patient positioning, contrast agent and volume, injectate content (steroid type, concentration, volume, local anesthetic), fluoroscopy confirmation language (“contrast outlined the nerve root sleeve with cephalad epidural spread; no vascular uptake observed”), patient tolerance, and post-procedure monitoring note. The template flags fluoroscopy guidance (77003) as a bundled service post-2017 for transforaminal ESI to prevent a separate charge that will be denied.
• Medial branch block and facet injection template: The medial branch block template includes a 30-minute and 2-hour pain relief percentage field. These relief measurements are the clinical evidence required to establish RFA candidacy. OmniMD tracks block results across a patient’s encounter history and generates the diagnostic block summary automatically when the prior authorization for RFA is initiated. Payers require documentation of two separate diagnostic blocks with 50 to 80 percent relief before approving RFA. Without a structured template capturing these specific relief percentages, the prior authorization will fail and the RFA will be denied.
• Radiofrequency ablation (RFA) documentation: OmniMD’s RFA template pulls the documented diagnostic block results from the patient’s encounter history and includes them automatically in the procedure note. The template requires: electrode placement confirmation, generator settings (temperature or impedance), lesion duration, post-procedure neurological assessment, and a post-procedure pain assessment using the same validated scale used at the diagnostic block visits. This creates a longitudinal record that supports both the medical necessity of the procedure and the billing for each level (64635 base + 64636 add-on for each additional lumbar level).
• Spinal cord stimulator trial and permanent implant documentation: The SCS trial template (63650) captures trial lead placement, stimulation parameters, paresthesia coverage mapping, and the patient’s daily pain diary results for the trial period. At trial conclusion, OmniMD calculates the average pain relief percentage across the trial period and displays the result against the 50 percent threshold required for permanent implant authorization. The permanent implant template (63685) references the trial success documentation automatically, linking both encounters for the payer’s prior authorization review. See the medical billing software page for how OmniMD handles SCS prior authorization across Medicare and commercial payers.
• Prior authorization workflow for interventional procedures: The AI RCM module tracks prior authorization status for every scheduled interventional procedure. Authorization requirements for pain management procedures are among the most stringent in outpatient medicine: ESI authorizations typically require imaging confirming structural pathology, documentation of failed conservative care, and the number and dates of prior injections at the same site. RFA authorizations require the two positive diagnostic block records. SCS authorizations require psychology clearance, a minimum 6-month conservative care failure history, and the trial success documentation. OmniMD generates the prior authorization request from structured fields in the patient record rather than requiring the office staff to re-enter clinical data into the payer portal.

ICD-10 Codes for Pain Management Diagnoses

Pain management ICD-10 coding requires specificity beyond the presenting symptom. The G89 chronic pain category must be used as a secondary code when a specific underlying condition is also coded, not as the primary diagnosis when the underlying etiology is known. The Z79.891 code for long-term opioid use must appear on every claim for a patient on chronic opioid therapy. Using R52 (unspecified pain) as a primary diagnosis when a more specific code is available is an audit trigger. OmniMD’s diagnosis selection includes code-specific notes on sequencing rules, laterality requirements, and Z-code co-coding obligations.

Outcome Measures and MIPS Quality Reporting for Pain Management

Pain management outcome measures serve three simultaneous functions: they document functional change for the clinical record, provide the threshold-based evidence payers require for medical necessity on interventional procedure authorizations, and generate the data required for MIPS quality measure reporting. A pain score collected on paper at a single visit that is not stored in the EHR serves none of these three purposes. OmniMD collects, scores, and stores all standard pain management outcome measures inside the visit note, trends them longitudinally across the episode of care, and uses the documented improvement thresholds directly in prior authorization summaries.

MIPS Quality Measures for Pain Management Practices

Pain management practices participating in MIPS have two directly applicable quality measures that OmniMD tracks automatically:

• MIPS #131 – Pain Assessment and Follow-Up: Requires that a validated pain assessment instrument be used at each visit and that a follow-up plan be documented when pain is identified. OmniMD satisfies this measure automatically when the NRS, VAS, or PEG score is captured in the visit note and the assessment and plan includes a documented pain management response. The measure denominator applies to all patients aged 18 and older with an office or outpatient visit; the numerator requires both the pain assessment and the follow-up plan documented in the same encounter.
• MIPS #477 – Multimodal Pain Management Plan: Requires documentation that the treatment plan addresses at least two of the following components: interventional procedures, pharmacologic therapy, physical or occupational therapy, and behavioral health. Pain management practices treating patients with both injections and opioid therapy already satisfy both components, but the plan documentation must explicitly name both modalities. OmniMD’s pain management note template includes a structured multimodal plan section that satisfies this requirement when completed. See the remote patient monitoring page for how OmniMD’s RTM data supports the behavioral monitoring component of MIPS #477 documentation.

Who Should Use OmniMD Pain Management EHR?

OmniMD’s pain management EHR is built for practices that perform interventional procedures alongside opioid and non-opioid medication management, and that need controlled substance compliance documentation, procedure-specific billing, and outcome measure collection inside a single system. The following practice types get the most value from OmniMD’s pain management configuration.

• Interventional pain management practices: Practices performing ESI, facet blocks, RFA, trigger point injections, and nerve blocks need procedure-specific note templates and prior authorization workflows for each procedure type. OmniMD provides a distinct template for each procedure category with required fields that prevent incomplete documentation before the note is signed, and prior authorization tracking linked to each scheduled procedure that confirms authorization status before the day of service.
• Opioid management and chronic pain clinics: Practices managing large chronic opioid therapy panels need PDMP auto-check, MME tracking, ORT and SOAPP-R screening, controlled substance agreement renewal tracking, and UDS workflow all operating within the visit note rather than across separate systems. OmniMD integrates all of these functions into a single chronic pain follow-up visit template that a provider can complete in a fraction of the time required when these tools are accessed through separate portals and platforms.
• Multi-provider pain management centers: Pain centers with multiple providers across interventional, medication management, and behavioral health need a shared patient record that reflects the contributions of each provider to the multimodal treatment plan. OmniMD’s shared patient record allows the interventional provider’s procedure notes, the pharmacist’s medication review, and the psychologist’s behavioral assessment to appear in the same patient chart, satisfying the MIPS #477 multimodal plan documentation requirement across provider roles.
• Spinal cord stimulator programs: SCS implant programs require a documentation trail that spans the pre-authorization phase (conservative care failure, psychology clearance), the trial phase (percutaneous lead placement, daily pain diary, trial success calculation), and the permanent implant phase (IPG placement, programming visits). OmniMD manages the entire SCS episode as a linked care pathway, with each phase’s documentation automatically included in the authorization request for the next phase. The AI RCM module handles SCS prior authorization separately from the routine injection authorization queue, with a dedicated submission workflow for the psychology clearance, trial result, and imaging records required by each major commercial payer.
• Worker’s compensation pain practices: Worker’s compensation pain management requires injury documentation, work-relatedness determination, functional capacity assessment, return-to-work status, and state-specific form generation alongside the standard clinical documentation. OmniMD includes worker’s comp fields in the pain management template and routes worker’s comp claims through the applicable state fee schedule separately from the Medicare and commercial billing queue.
• Practices adding G3002/G3003 chronic pain management services: The 2026 chronic pain management codes (G3002/G3003) allow pain management practices to bill a monthly service for the ongoing care coordination of complex chronic pain patients, generating $95 to $143 per patient per month in additional revenue without a face-to-face visit. Eligibility requires an established patient relationship (typically the prior year’s billing), a documented care plan, patient consent, and at least 30 minutes of clinical time per month. OmniMD’s G3002/G3003 workflow tracks time, documents care plan updates, captures patient consent, and generates the monthly billing automatically. See the EHR software hub for how OmniMD manages G3002/G3003 billing across multi-specialty practices that include pain management.